Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
LeBlanc FR, Hasanali ZS, Stuart A, Shimko S, Sharma K, Leshchenko VV, Parekh S, Fu H, Zhang Y, Martin MM, Kester M, Fox T, Liao J, Loughran TP, Evans J, Pu JJ, Spurgeon SE, Aladjem MI, Epner EM. LeBlanc FR, et al. Among authors: hasanali zs. Oncotarget. 2022 Aug 16;13:986-1002. doi: 10.18632/oncotarget.28258. eCollection 2022. Oncotarget. 2022. PMID: 36093297 Free PMC article.
Flipping the cyclin D1 switch in mantle cell lymphoma.
Hasanali Z, Sharma K, Epner E. Hasanali Z, et al. Best Pract Res Clin Haematol. 2012 Jun;25(2):143-52. doi: 10.1016/j.beha.2012.03.001. Epub 2012 May 4. Best Pract Res Clin Haematol. 2012. PMID: 22687450 Review.
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Spurgeon SE, Sharma K, Claxton DF, Ehmann C, Pu J, Shimko S, Stewart A, Subbiah N, Palmbach G, LeBlanc F, Latour E, Chen Y, Mori M, Hasanali Z, Epner EM. Spurgeon SE, et al. Br J Haematol. 2019 Sep;186(6):845-854. doi: 10.1111/bjh.16008. Epub 2019 Jun 9. Br J Haematol. 2019. PMID: 31177537 Free article. Clinical Trial.
Cyclophosphamide as a first-line therapy in LGL leukemia.
Moignet A, Hasanali Z, Zambello R, Pavan L, Bareau B, Tournilhac O, Roussel M, Fest T, Awwad A, Baab K, Semenzato G, Houot R, Loughran TP Jr, Lamy T. Moignet A, et al. Leukemia. 2014 May;28(5):1134-6. doi: 10.1038/leu.2013.359. Epub 2013 Nov 27. Leukemia. 2014. PMID: 24280867 Free PMC article. No abstract available.
17 results